ArticleCureus2025
Performance of a New Tabletop Non-mydriatic Fundus Camera for Single-Field Diabetic Retinopathy Detection: A Pilot Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiabetic retinopathy (DR) detection is made easy with the use of a fundus camera. The evidence of the use of a fundus camera for DR detection in non-mydriatic conditions with limited technical challenges is scarce. This is a pilot study that evaluates the performance of the Oivi fundus camera (Oivi AS, Oslo, Norway), a novel non-mydriatic tabletop fundus camera for DR detection using a single-field, macula-centered imaging approach. Its diagnostic accuracy was compared with that of a standard reference device, the Topcon NW400 fundus camera (Topcon Corporation, Tokyo, Japan).
methodsA total of 243 subjects with diabetes mellitus (DM) were recruited. Non-mydriatic macula-centered images were captured using both cameras. Two ophthalmologists independently graded the deidentified images for image quality and DR stage. Discrepancies between their assessments were adjudicated by consensus after review by a senior ophthalmologist. The senior ophthalmologist's grading of images from the standard camera images served as the ground truth for comparative analysis. Inter-modality agreement was evaluated using linear weighted kappa (κ) correlation.
resultsDR was detected in 23% of patients using the standard reference camera (12% of eyes) and in 23.86% using the tabletop camera (12.6%). Identification of moderate non-proliferative diabetic retinopathy (NPDR) (7.2%), severe NPDR (0.4%), and proliferative diabetic retinopathy (PDR) (1.23%) was similar between the two cameras, although not always in the same eyes. The inter-modality agreement (k) for DR was 0.927 (95% CI: 0.88-0.97) (almost perfect). The tabletop camera showed a sensitivity of 92.98% (95% CI, 83-98.05%) and a specificity of 99.47% (95% CI, 98.10-99.94%) for DR. The percentage of usable images was 92.3% with the standard reference camera and 95.2% with the tabletop camera.
conclusionsThis study provides preliminary evidence that the novel tabletop Oivi fundus camera may offer comparable performance to standard non-mydriatic devices for DR detection in a single-field strategy. Its portability and usability under mesopic conditions suggest potential value for point-of-care screening. Further large-scale studies are warranted to validate these findings and explore their role in screening programs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.